Parabilis Medicines, Inc. PBLS
Set alert
27.25 USD -1.07 -3.78%
At close
28.99 +1.74 +6.39%
Pre-market · Nov 3, 7:10 AM ET
26.87 Day range 28.55
22.66 52-week range 42.49
- YTD
- -13.77%
- 1 year
- -13.77%
- Open
- 28.13
- Prev close
- 28.32
- Mkt cap
- 3.37B
- Vol
- 702.26K
- Avg vol
- 893.41K
- EPS
- -9.51
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 26.87
- High
- 28.55
- Forward P/E
- -12.46
- Beta
- 0.00
- Short ratio
- 7.03
- Inst. own
- 82.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 32.96
- 200-d avg
- 32.22
- 1y target
- 41.40
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 41.40 +51.9% upside
Now 27.25
- Target (low)
- 40.00
- Target (mean)
- 41.40
- Target (high)
- 45.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy0
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.38 | -0.45 – -0.25 | 0.00 | 0.0% | 500.00K | 0.0% | 3 |
| Next quarter | -0.39667 | -0.47 – -0.26 | 0.00 | 0.0% | 1.00M | 0.0% | 3 |
| Current year | -2.58 | -3.09 – -1.63 | 0.00 | 0.0% | 1.19M | 0.0% | 3 |
| Next year | -2.19 | -3.37 – -1.19 | -2.58 | +15.1% | 4.75M | +300.2% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 22, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| Jul 6, 2026 | Guggenheim | Initiated | — | Buy |
| Jul 6, 2026 | Leerink Partners | Initiated | — | Outperform |
| Jul 6, 2026 | B of A Securities | Initiated | — | Buy |